AstraZeneca, Nektar constipation drug wins European approval
December 09, 2014 at 02:41 AM EST
LONDON, Dec 9 (Reuters) - AstraZeneca's new drug for the treatment of opioid-induced constipation, which was developed with Nektar Therapeutics, has been approved in the European Union, the British company said on Tuesday.
